Looking to publish in Jpad-journal Of Prevention Of Alzheimers Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThe Journal of Prevention of Alzheimer’s Disease (JPAD) is an e-only Gold Open Access journal that publishes reviews, original research articles and short reports to improve knowledge in Alzheimer's disease prevention, including neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trial design, and health economics outcomes. It also publishes meeting abstracts from the Clinical Trial on Alzheimer's Disease (CTAD) Conference and is indexed in MEDLINE, SCIE (WoS), and Scopus.
Looking to publish in Jpad-journal Of Prevention Of Alzheimers Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Jpad-journal Of Prevention Of Alzheimers Disease accepts the following article types. Click on an article type to view submission instructions.
Original Papers
Reviews
Brief Reports
Letters To The Editor
Recent Publications
Neuropsychiatric symptoms and dementia development: a 15-year population-based study
Francesca Remelli, Giulia Grande, Serhiy Dekhtyar, Erika J Laukka, Caterina Trevisan, Stefano Volpato, Laura Fratiglioni, Federico Triolo
Interaction of diet and physical activity on dementia risk: the Rotterdam study
Muhammed Lamin Sambou, M. Arfan Ikram, M. Kamran Ikram, Jeremy A. Labrecque, Frank J. Wolters
Epigenetic aging and blood based neurodegeneration markers in LASI-DAD
Jung Ki Kim, Thalida E. Arpawong, Bharat Thyagarajan, Jennifer A. Smith, Sithara Vivek, Scott Ratliff, Sharmistha Dey, Jinkook Lee, Eileen M. Crimmins
Income, diet, and cognitive function: observational analyses and candidate metabolomic pathways identified by Mendelian randomization
Xingguang Zhao, Weijian Wu, Qiaoxuan Zhang, Mengqian Ouyang, Haoyu Luo, Qun Yu, Yingren Mai, Zhiyu Cao, Shaoqing Yang, Mingsong Xu, Jun Liu, Wang Liao
Hazan J; Liu KY; Howard R. Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE4 heterozygotes and non-carriers. # TJPAD-D-26-00165
Lutz Froelich
Frequently asked questions
How long does it take to publish?
6 days submission to first decision; 31 days submission to decision after review; 64 days submission to acceptance.
Reformat to Jpad-journal Of Prevention Of Alzheimers Disease using Livewrite PremiumIs a cover letter required?
A cover/response letter is required when submitting a revised manuscript, with a point-by-point response to reviewers’ comments.
Reformat to Jpad-journal Of Prevention Of Alzheimers Disease using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 4060 excluding taxes for all articles.
Reformat to Jpad-journal Of Prevention Of Alzheimers Disease using Livewrite Premium